Real-time enrollment status for this allergic conjunctivitis clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 1:37 PM UTC
| NCT Number | NCT06686472 |
| Recruiting Status | Recruiting |
| Condition | Allergic Conjunctivitis |
| Phase | Clinical Trial |
| Target Enrollment | 66 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Telios Pharma, Inc. |
| Last Updated on CT.gov | November 13, 2024 (Nov 13, 2024) |
As of July 13, 2026: Clinical trial NCT06686472 is currently recruiting participants. This clinical trial study for allergic conjunctivitis is actively seeking new participants at 1 location across the United States. The study is sponsored by Telios Pharma, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06686472 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06686472 was last updated Nov 13, 2024 (November 13, 2024). HelloStudys verifies this status automatically.